| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From Inserm UMR 533 (M.A., F.L.B., D.P., J.-J.S., J.N., H.L.M., J.M., D.E., I.B.), Université de Nantes, Nantes Atlantique Universités, linstitut du thorax, Faculté de Médecine, France; and the Department of Physiology (R.W.), Academic Medical Center, University of Amsterdam, the Netherlands.
Correspondence to Isabelle Baró, Inserm UMR533, linstitut du thorax, Faculté de Médecine, 1, rue G. Veil, 44035 Nantes Cedex, France. E-mail isabelle.baro{at}nantes.inserm.fr
The voltage-sensitive Na+ channel Nav1.5 plays a crucial role in generating and propagating the cardiac action potential and its dysfunction promotes cardiac arrhythmias. The channel takes part into a large molecular complex containing regulatory proteins. Thus, factors that modulate its biosynthesis, localization, activity, and/or degradation are of great interest from both a physiological and pathological standpoint. Using a yeast 2-hybrid screen, we unveiled a novel partner, 14-3-3
, interacting with the Nav1.5 cytoplasmic I interdomain. The interaction was confirmed by coimmunoprecipitation of 14-3-3 and full-length Nav1.5 both in COS-7 cells expressing recombinant Nav1.5 and in mouse cardiac myocytes. Using immunocytochemistry, we also found that 14-3-3 and Nav1.5 colocalized at the intercalated discs. We tested the functional link between Nav1.5 and 14-3-3
using the whole-cell patch-clamp configuration. Coexpressing Nav1.5, the ß1 subunit and 14-3-3
induced a negative shift in the inactivation curve of the Na+ current, a delayed recovery from inactivation, but no changes in the activation curve or in the current density. The negative shift was reversed, and the recovery from inactivation was normalized by overexpressing the Nav1.5 cytoplasmic I interdomain interacting with 14-3-3
. Reversal was also obtained with the dominant negative R56,60A 14-3-3
mutant, suggesting that dimerization of 14-3-3 is needed for current regulation. Computer simulations suggest that the absence of 14-3-3 could exert proarrhythmic effects on cardiac electrical restitution properties. Based on these findings, we propose that the 14-3-3 protein is a novel component of the cardiac Na+ channel acting as a cofactor for the regulation of the cardiac Na+ current.
Key Words: Na+ channel auxiliary subunit congenital heart disease
This article has been cited by other articles:
![]() |
L. Wu, S. L. Yong, C. Fan, Y. Ni, S. Yoo, T. Zhang, X. Zhang, C. A. Obejero-Paz, H.-J. Rho, T. Ke, et al. Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5 J. Biol. Chem., March 14, 2008; 283(11): 6968 - 6978. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta} Circ. Res., March 16, 2007; 100(5): e59 - e71. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. RUKNUDIN and E. G. LAKATTA The Regulation of the Na/Ca Exchanger and Plasmalemmal Ca2+ ATPase by Other Proteins Ann. N.Y. Acad. Sci., March 1, 2007; 1099(1): 86 - 102. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |